Healthcare & Biotech
Pro Medicus Share Price Falls 5% as Healthcare’s Rally Runs Out of Road
Same sell-off, different stories. Pro Medicus has a real question. ResMed has less new news.
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
All the latest Investor Standard news and insights delivered straight to your inbox.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
5 Quality Value ASX Stocks in a Market That Still Looks Mispriced
Summary This weeks ASX stocks in focus setup starts with a simple observation: the Australian market is not broadly cheap,…
Dividend Portfolio Series: 5 Growth Dividend Stocks You Should Own in 2026
1. Apple Inc.: NASDAQ Apple Inc. is viewed as a strong dividend stock because it pairs dependable income with steady…
An Outlook on ASX: Ramsay Health Care (RHC)
Business Summary & Overview Ramsay Health Care is a prominent international hospital operator offering acute care, surgical services, mental health…
Hims & Hers and the AUD $1.6 Bn Eucalyptus Deal
Eucalyptus: Business Description and Overview Eucalyptus is a Sydney‑based direct‑to‑consumer telehealth company that operates several targeted digital health clinics. Each…

Monthly Investor Memo
Delivered Monthly - 2026